This article is published in the forthcoming issue.

Rare case of small bowel inflammatory myofibroblastic tumor

Rare small bowel inflammatory myofibroblastic tumor

Authors

Keywords:

inflammatory myofibroblastic tumor (IMT), small intestine neoplasm, chronic secondary anemia, rare gastrointestinal neoplasms

Abstract

The inflammatory myofibroblastic tumor (IMT) is a rare mesenchymal neoplasm with variable biological behavior, which predominantly affects the lungs but can also appear in extrapulmonary sites, including the gastrointestinal tract. When situated in the small intestine, IMT presents substantial diagnostic and therapeutic difficulties. This case emphasizes the complications in diagnosing and surgically managing IMT in an unusual location. A patient, aged 67 with a past record of secondary iron-deficiency anemia, underwent a diagnostic examination due to gastrointestinal symptoms. The esophagogastroduodenoscopy showed a minor hiatal hernia, while a 5 mm hyperemic polyp, confirmed as a tubular adenoma, was identified by colonoscopy. Further MR enterography imaging detected a polypoid tumor approximately 28 mm in the right iliac region, which led to surgical intervention. A lower midline laparotomy revealed an intraluminal tumor in the proximal ileum, 60 cm from the ileocecal valve. A 20 cm segment of the impacted bowel was resected and an end-to-end ileo-ileal anastomosis was successfully achieved. The diagnosis of IMT with an R0 resection was confirmed through histopathological and immunohistochemical analysis. This case underlines the significance of considering IMTs in the differential diagnosis of unexplained gastrointestinal symptoms and highlights the role of imaging and surgical resection in reaching definitive management. Boosting awareness of IMTs in medical practice can lead to earlier recognition and improved patient outcomes.

Downloads

Download data is not yet available.

References

Brunn H. Two interesting benign lung tumors of contradictory histopathology: Remarks on the necessity for maintaining the chest tumor registry. J Thorac Surg. 1939;9(2):119-31. doi:10.1016/S0096-5588(20)32030-4.

Rezaii Salim M, Vahedi H, Salimi Z, Froutan H, Sotoudeh M. Inflammatory myofibroblastic tumor of the small bowel: a case report. Middle East J Dig Dis. 2011 Sep;3(2):134-7. PMID: 25197546; PMCID: PMC4154918.

Gleason BC, Hornick JL. Inflammatory myofibroblastic tumours: where are we now? J Clin Pathol. 2008 Apr;61(4):428-37. doi: 10.1136/jcp.2007.049387. Epub 2007 Oct 15. PMID: 17938159.

Coffin CM, Watterson J, Priest JR, Dehner LP. Extrapulmonary inflammatory myofibroblastic tumor (inflammatory pseudotumor). A clinicopathologic and immunohistochemical study of 84 cases. Am J Surg Pathol. 1995 Aug;19(8):859-72. doi: 10.1097/00000478-199508000-00001. PMID: 7611533.

Dishop MK, Warner BW, Dehner LP, Kriss VM, Greenwood MF, Geil JD, et al. Successful treatment of inflammatory myofibroblastic tumor with malignant transformation by surgical resection and chemotherapy. J Pediatr Hematol Oncol. 2003 Feb;25(2):153-8. doi: 10.1097/00043426-200302000-00014. PMID: 12571469.

Telugu RB, Prabhu AJ, Kalappurayil NB, Mathai J, Gnanamuthu BR, Manipadam MT. Clinicopathological study of 18 cases of inflammatory myofibroblastic tumors with reference to ALK-1 expression: 5-year experience in a tertiary care center. J Pathol Transl Med. 2017;51(3):255-63. doi: 10.4132/jptm.2017.01.12.

Taiymi A, Meryem N, Bouziane M, Zazour A, Kharrasse G, Khannoussi W, et al. Abdominal inflammatory myofibroblastic tumour presenting as a pancreatic mass: A case report. Cureus. 2023 Jun 30;15(6):e41213. doi: 10.7759/cureus.41213. PMID: 37525776; PMCID: PMC10387333.

Coffin CM, Hornick JL, Fletcher CDM. Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases. Am J Surg Pathol. 2007 May;31(4):509-20. doi: 10.1097/01.pas.0000213393.57322.c7.

Siemion K, Reszec-Gielazyn J, Kisluk J, Roszkowiak L, Zak J, Korzynska A. What do we know about inflammatory myofibroblastic tumors? – A systematic review. Adv Med Sci. 2022;67(1):129-38. doi: 10.1016/j.advms.2022.02.002.

Butrynski JE, D'Adamo DR, Hornick JL, Dal Cin P, Antonescu CR, Jhanwar SC, et al. Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor. N Engl J Med. 2010 Oct 28;363(18):1727-33. doi: 10.1056/NEJMoa1007056. PMID: 20979472; PMCID: PMC3014292.

Downloads

Published

2025-10-04

Issue

Section

Case Report

How to Cite

1.
Trifunović N, Mitrović N, Stevanović D, Jašarović D, Trifunović J. Rare case of small bowel inflammatory myofibroblastic tumor: Rare small bowel inflammatory myofibroblastic tumor. J Surg Med [Internet]. 2025 Oct. 4 [cited 2025 Oct. 9];9(10):00-. Available from: https://jsurgmed.com/article/view/8154